May 28, 2009 - Stereotactic body radiotherapy (SBRT) when used to treat certain patients with non-small-cell lung cancer provided a 3-year local tumor control rate of 90 percent or higher with minor toxicity, reported Scandinavian researchers report in a May 4th online edition of the Journal of Clinical Oncology.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now